EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

IL-4 and TGF-β regulate inflammatory cytokines and cellular infiltration in the lung and systemic IL-6 in mouse-adapted SARS-CoV-2 infection

Solomon Taye Sima, Lucinda Puebla-Clark, Maria Gonzalez-Orozco, Mark Joseph Endrino, Thomas R Shelite, Hsiang-Chi Tseng, Yazmin B Martinez-Martinez, Matthew B Huante, Hannah G Federman, Komi Gbedande, Vineet D Menachery, Mark C Siracusa und 5 weitere

ImmunoHorizons · 25.08.2025 · 9 (9)

DOI: 10.1093/immhor/vlaf032 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ImmunoHorizons, online erschienen am 25.08.2025. Verfasst von Solomon Taye Sima und 16 weiteren Autor:innen. Beteiligte Einrichtung: Center for Immunity and Inflammation, New Jersey Medical School, Rutgers Health, Newark, NJ, United States. Hauptthemen laut MEDLINE: COVID-19, Lung, SARS-CoV-2, Transforming Growth Factor beta. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NINDS NIH HHS, University of Texas Medical Branch Institute for Human Infection and Immunity.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The pathology of severe COVID-19 is due to a hyperinflammatory immune response persisting after viral clearance. To understand how the immune response to SARS-CoV-2 is regulated to avoid severe COVID-19, we tested relevant immunoregulatory cytokines. Transforming growth factor β (TGF-β), interleukin (IL)-10, and IL-4 were neutralized upon infection with mouse-adapted SARS-CoV-2 (CMA3p20), a model of mild disease; lung inflammation was quantified by histology and flow cytometry at early and late time points. Mild weight loss and lung inflammation including consolidation and alveolar thickening were evident 3 d postinfection (dpi), and inflammation persisted to 7 dpi. Coinciding with early monocytic infiltrates, CCL2 and granulocyte colony-stimulating factor were transiently produced 3 dpi, while IL-12 and CCL5 persisted to 7 dpi, modeling viral and inflammatory phases of disease. Neutralization of TGF-β, but not IL-10 or IL-4, significantly increased lung inflammatory monocytes and elevated serum but not lung IL-6. Neutralization of IL-4 prolonged weight loss and increased early perivascular infiltration without changing viral titer. Anti-IL-4 reduced expression of Arg1, a gene associated with alternative activation of macrophages. Neutralizing TGF-β and IL-4 had differential effects on pathology after virus control. Lung perivascular infiltration was reduced 7 dpi by neutralization of IL-4 or TGF-β, and periairway inflammation was affected by anti-TGF-β, while alveolar infiltrates were not affected by either. Anti-IL-4 prolonged IL-12 to 7 dpi along with reduced IL-10 in lungs. Overall, the immunoregulatory cytokines TGF-β and IL-4 dampen initial inflammation in this mouse-adapted SARS-CoV-2 infection, suggesting that promotion of immunoregulation could help patients in early stages of disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19LungSARS-CoV-2Transforming Growth Factor betaInterleukin-4CytokinesInterleukin-6AnimalsMiceDisease Models, AnimalFemaleMice, Inbred C57BLInterleukin-10

Stichwörter der Autor:innen

IL-4SARS-CoV-2TGF-βcytokinesimmunoregulation

Substanzen

Transforming Growth Factor betaInterleukin-4CytokinesInterleukin-6Interleukin-10Il4 protein, mouse

Autor:innen und Institutionen

  • Center for Immunity and Inflammation, New Jersey Medical School, Rutgers Health, Newark, NJ, United States.
  • Division of Infectious Diseases, Department of Internal Medicine, University of Texas Medical Branch, Galveston, TX, United States.
  • Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, United States.
  • Department of Pathology, University of Texas Medical Branch, Galveston, TX, United States.
  • Center for Virus-Host-Innate Immunity and Department of Medicine, New Jersey Medical School, Rutgers Health, Newark, NJ, United States.
  • Department of Pharmacology, Physiology and Neuroscience, New Jersey Medical School, Rutgers Health, Newark, NJ, United States.

Förderung

  • NIAID NIH HHS
  • NINDS NIH HHS
  • University of Texas Medical Branch Institute for Human Infection and Immunity
  • McLaughlin Fund, the Sealy Foundation at the University of Texas Medical Branch

Zitieren

APA

Taye Sima, S., Puebla-Clark, L., Gonzalez-Orozco, M., Endrino, M. J., Shelite, T. R., Tseng, H. C., Martinez-Martinez, Y. B., Huante, M. B., Federman, H. G., Gbedande, K., Menachery, V. D., Siracusa, M. C., Endsley, M. A., Dann, S. M., Endsley, J. J., Rajsbaum, R., & Stephens, R. (2025). IL-4 and TGF-β regulate inflammatory cytokines and cellular infiltration in the lung and systemic IL-6 in mouse-adapted SARS-CoV-2 infection. ImmunoHorizons, 9(9). https://doi.org/10.1093/immhor/vlaf032

Vancouver

Taye Sima S, Puebla-Clark L, Gonzalez-Orozco M, Endrino MJ, Shelite TR, Tseng HC, et al. IL-4 and TGF-β regulate inflammatory cytokines and cellular infiltration in the lung and systemic IL-6 in mouse-adapted SARS-CoV-2 infection. ImmunoHorizons. 2025;9(9). doi:10.1093/immhor/vlaf032

BibTeX
@article{TayeSima2025,
  author = {Taye Sima, Solomon and Puebla-Clark, Lucinda and Gonzalez-Orozco, Maria and Endrino, Mark Joseph and Shelite, Thomas R and Tseng, Hsiang-Chi and Martinez-Martinez, Yazmin B and Huante, Matthew B and Federman, Hannah G and Gbedande, Komi and Menachery, Vineet D and Siracusa, Mark C and Endsley, Mark A and Dann, Sara M and Endsley, Janice J and Rajsbaum, Ricardo and Stephens, Robin},
  title = {IL-4 and TGF-β regulate inflammatory cytokines and cellular infiltration in the lung and systemic IL-6 in mouse-adapted SARS-CoV-2 infection},
  journal = {ImmunoHorizons},
  year = {2025},
  volume = {9},
  number = {9},
  doi = {10.1093/immhor/vlaf032}
}
Kostenlos starten →